A Study of Deucravacitinib to Treat LPP and FFA
NCT06091956 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2025-06-08
Summary
The purpose of this clinical research study is to learn more about the use of Deucravacitinib in the treatment of Lichen Planopilaris.
Conditions
- Lichen Planopilaris
Interventions
- DRUG
-
6 milligram (mg) orally administrated, twice daily
Sponsors & Collaborators
- collaborator INDUSTRY
- lead OTHER
Principal Investigators
-
Aaron Mangold, MD · Mayo Clinic
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-11-07
- Primary Completion
- 2024-05-21
- Completion
- 2024-12-24
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Study of the Comparative Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in Japan (RePhlect)
NCT06382987 ·Status: RECRUITING
-
Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis
NCT00090129 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis
NCT02635204 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy
NCT06643260 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus
NCT05593432 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of DLX105-DMP in Subjects With Plaque Psoriasis
NCT04203433 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp Psoriasis
NCT02932462 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of ARQ-154 Foam in Adolescent and Adult Subjects With Scalp and Body Psoriasis
NCT04128007 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis
NCT03895372 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis
NCT03850483 ·Status: COMPLETED ·Phase: PHASE2
-
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Moderate Chronic Plaque-type Psoriasis
NCT02872285 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis
NCT02933866 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of a Novel Ointment to Treat Plaque Type Psoriasis
NCT01029405 ·Status: COMPLETED ·Phase: PHASE2
-
Intra-dermal Injections of DLX105 Into Lesional Skin in Patients With Mild-to-moderate Psoriasis Vulgaris
NCT01595997 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque Psoriasis
NCT03837743 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3 Clinical Study of KHK4827
NCT01782924 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Injectable Platelet Rich Fibrin in Lichen Planus
NCT03265093 ·Status: COMPLETED ·Phase: NA
-
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305)
NCT01882647 ·Status: COMPLETED ·Phase: PHASE3
-
Topical Double-blind, Randomized, Placebo-controlled Study in Psoriasis Patients
NCT01936337 ·Status: COMPLETED ·Phase: PHASE2
-
Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis
NCT02969018 ·Status: COMPLETED ·Phase: PHASE2
-
Topical Ruxolitinib Lichen Planus
NCT03697460 ·Status: COMPLETED ·Phase: PHASE2
-
Psoriasis Inflammation and Systemic Co Morbidities
NCT01170715 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis
NCT03469336 ·Status: COMPLETED ·Phase: PHASE1
-
Valchlor in the Treatment of Lichen Planopilaris
NCT03417141 ·Status: COMPLETED ·Phase: PHASE2
-
Moderate to Severe Plaque Psoriasis With Scalp Involvement
NCT00791765 ·Status: COMPLETED ·Phase: PHASE4